news.volyx.in

FDA Designates MM120 (LSD) Breakthrough Therapy for Generalized Anxiety Disorder (businesswire.com)

122 points by beefman · 891 days ago · 65 comments on HN

The AI summary for this story hasn't been generated yet — it's produced hourly. Check back soon. Meanwhile, read the discussion on HN.